Pancreas and prostate cancers bearing oncogenic mutations in KRAS or PTEN, respectively, use amino acids derived from engulfed extracellular proteins to proliferate in nutrient-limiting environments3,4,8–10. This evidence concerns the gene PTEN and prostate carcinoma.